Literature DB >> 12480867

Galantamine may be effective in treating autistic disorder.

Helmut Niederhofer, W Staffen, A Mair.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12480867      PMCID： PMC1124870          DOI： 10.1136/bmj.325.7377.1422/a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Methylphenidate treatment of hyperactive autistic children.

Authors:  B Birmaher; H Quintana; L L Greenhill
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1988-03       Impact factor: 8.829

2.  Psychometric characteristics of the aberrant behavior checklist.

Authors:  M G Aman; N N Singh; A W Stewart; C J Field
Journal:  Am J Ment Defic       Date:  1985-03

3.  Tardive and withdrawal dyskinesia in autistic children: a prospective study.

Authors:  M Campbell; P Adams; R Perry; E K Spencer; J E Overall
Journal:  Psychopharmacol Bull       Date:  1988

4.  Response to triiodothyronine and dextroamphetamine: a study of preschool schizophrenic children.

Authors:  M Campbell; B Fish; R David; T Shapiro; P Collins; C Koh
Journal:  J Autism Child Schizophr       Date:  1972 Oct-Dec

5.  Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.

Authors:  G K Wilcock; S Lilienfeld; E Gaens
Journal:  BMJ       Date:  2000-12-09
  5 in total
  18 in total

Review 1.  Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature.

Authors:  J Helen Yoo; Maria G Valdovinos; Dean C Williams
Journal:  J Autism Dev Disord       Date:  2007-01-13

2.  Treatment of Autism Spectrum Disorder in Children and Adolescents.

Authors:  Melissa DeFilippis; Karen Dineen Wagner
Journal:  Psychopharmacol Bull       Date:  2016-08-15

Review 3.  Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.

Authors:  Tatiana M Kazdoba; Prescott T Leach; Mu Yang; Jill L Silverman; Marjorie Solomon; Jacqueline N Crawley
Journal:  Curr Top Behav Neurosci       Date:  2016

4.  Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures.

Authors:  Benjamin L Handen; Cynthia R Johnson; Sarah McAuliffe-Bellin; Patricia Jo Murray; Antonio Y Hardan
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-02       Impact factor: 2.576

Review 5.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

Review 6.  Pharmacotherapy for the core symptoms in autistic disorder: current status of the research.

Authors:  Cristan Farmer; Audrey Thurm; Paul Grant
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

Review 7.  Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Authors:  Michael G Aman; Cristan A Farmer; Jill Hollway; L Eugene Arnold
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-10

Review 8.  Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.

Authors:  D A Rossignol; R E Frye
Journal:  Mol Psychiatry       Date:  2011-01-25       Impact factor: 15.992

9.  What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?

Authors:  Graham E Ewing
Journal:  N Am J Med Sci       Date:  2009-07

Review 10.  Mitochondrial dysfunction: A hidden trigger of autism?

Authors:  Vellingiri Balachandar; Kamarajan Rajagopalan; Kaavya Jayaramayya; Madesh Jeevanandam; Mahalaxmi Iyer
Journal:  Genes Dis       Date:  2020-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.